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Introduction: The aim of this study was to conduct a systematic review and meta-analysis for determining the
effects of prehospital adrenaline administration on return of spontaneous circulation, hospital admission, survival to
discharge and discharge with cerebral performance category 1 or 2 in out-of-hospital cardiac arrest patients.
Methods: MEDLINE and Scopus databases were searched to identify studies reported to March 2014. Study
selection and data extraction were independently completed by two reviewers (PA and SR). The baseline
characteristics of each study and number of events were extracted. Risk ratios (RR) and 95% confidence interval (CI)
were estimated. Heterogeneity and publication bias were also explored.
Results: In total 15 studies were eligible and included in the study. Of 13 adult observational studies, four to eight
studies were pooled for each outcome. These yielded a total sample size that ranged from 2,381 to 421,459. A
random effects model suggested that patients receiving prehospital adrenaline were 2.89 times (95% CI: 2.36, 3.54)
more likely to achieve prehospital return of spontaneous circulation than those not administered adrenaline.
However, there were no significant effects on overall return of spontaneous circulation (RR = 0.93, 95% CI: 0.5, 1.74),
admission (RR = 1.05, 95% CI: 0.80, 1.38) and survival to discharge (RR = 0.69, 95% CI: 0.48, 1.00).
Conclusions: Prehospital adrenaline administration may increase prehospital return of spontaneous circulation, but
it does not improve overall rates of return of spontaneous circulation, hospital admission and survival to discharge.Introduction
Out of hospital cardiac arrest is one of the most urgent
Emergency Medical Service (EMS) priorities, in which only
23% of patients survive to hospital admission [1,2], and
only 7.6% survive to hospital discharge [1,2]. Factors identi-
fied as predictors of survival among out of hospital cardiac
arrest patients include the cardiac arrest being witnessed
by a bystander, arrest witnessed by EMS personnel, initially
shockable cardiac rhythms and bystander cardiopulmonary
resuscitation (CPR) [2]. Administration of adrenaline has
been a part of advanced life support guidelines for decades
[3], for both shockable and non-shockable cardiac rhythms
[4-7], to increase cardiac output and preferentially divert* Correspondence: sasivimol.rat@mahidol.ac.th
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article, unless otherwise stated.blood circulation to the heart and brain during CPR [3].
Animal models indicate that adrenaline administration
significantly increases the probability of return of spontan-
eous circulation (ROSC) [8-11]. However, evidence in
humans is limited, with most studies being observational
studies with inconsistent results on short term outcomes
including ROSC [5,12-18] and hospital admission [5,13,
14,16,18-21]. In addition, inconsistent results were also
found in long-term outcomes such as one-month survival
with good cerebral performance [14,18] and survival to
hospital discharge [5,14,16,18-20].
Although three systematic reviews [22-24] have been
conducted, a more complete review was still required for
the following reasons. One previous review studied a mix
of in- and out-of hospital cardiac arrest patients without
providing any quantitative conclusion [22], and another
systematic review pooled adrenaline effect on survival
to hospital discharge but not for prehospital ROSC [23].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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http://ccforum.com/content/18/4/463Finally, Lin et al. conducted a systematic review by includ-
ing only randomized controlled trials (RCTs), which pri-
marily aimed to compare the standard dosages of
adrenaline administration with placebo, vasopressin and
high dosage of adrenaline in out of hospital cardiac arrest
patients [24]. Although those authors found benefit of
adrenaline administration over placebo on ROSC and sur-
vival to admission, the results were based on only one1686 studies identified from database search
804 From SCOPUS 
882 From MEDLINE
1084 relevant studies identified from title and
abstract review
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Discharge alive with CP
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Figure 1 Flow of selection of studies.RCT. There have been more studies published since these
reviews were reported. We, therefore, conducted a system-
atic review and meta-analysis focused only on out of hos-
pital cardiac arrest patients, which aimed to determine the
effects of prehospital adrenaline administration on both
short (that is, ROSC, hospital admission) and long term
outcomes (that is, survival to discharge and discharged
with cerebral performance category (CPC) 1 or 2).1069 studies were excluded.   
404 animal studies
274 non interested population
240 non interested intervention
141 not interesting study designs
71 case report
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Table 1 Description of study and subject characteristics of included studies
Author, year
[reference]











Herlitz , 1994 [20] Sweden EMS 1,222 Cohort M Adult Asystole 66a 69.56 73 50 8.59 -
Dieckmann, 1995 [34] USA EMS 65 Cohort NT Children Mixed 1.51 64.62 - - - -
Herlitz, 1995 [5] Sweden EMS 1,203 Cohort M Adult VF 70a 79.7 - 85 19.7 -
Herlitz, 1995 [19] Sweden EMS 748 Cohort M Adult PEA 71a 67.11 76 75 8 -
Guyette, 2004 [17] USA EMS 298 Cohort NT Adult Mixed 63.5 58.05 - 43.96 28.19 3.8
Ong, 2007 [16] Singapore EMS 681 Cohort NT Adult Mixed 63.3 68.75 - 57.1 19.36 1
Vayrynen, 2008 [21] Findland EMS 789 Cohort M Adult PEA 66.7 61.85 45.75 56.15 23.07 3.8
Yanagawa, 2010 [15] Japan EMS 713 Cohort M Adult Mixed 68 59.89 85 42.5 33.52 -
Jacobs, 2011 [27] Australia EMS 534 RCT M Adult Mixed 63.5 72.85 91.39 48.31 51.12 5
Hagihara, 2012 [12] Japan EMS 417,188 Cohort M Adult Mixed 70 58.95 55.06 40.33 36.1 -
Hayashi, 2012 [13] Japan EMS 3,161 Cohort NT Adult Mixed 73.3 60.2 67.26 100 41.57 -
Machida, 2012 [18] Japan Hospital 492 Cohort M Adult Mixed 64 65.85 34.35 33.94 53.05 -
Nordseth, 2012 [14] Sweden EMS 174 Cohort NT Adult PEA 75a 64.16 56.65 57.23 40.46 -
Neset, 2013 [35] Sweden EMS 233 Cohort NT Adult Mixed 74 57.6 56.7 35.7 45.7 -
Goto, 2013 [36] Japan EMS 209,577 Cohort M Adult Mixed 68a 778.47 86.1 74.89 70.85 -
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Search strategy
This study followed Meta-Analysis Of Observational
Studies in Epidemiology (MOOSE) guidelines [25]. Be-
cause we worked on public data, neither approval nor
patient consent was required by the Ethics Committee
of the Faculty of Medicine, Ramathibodi Hospital,
Mahidol University. Two reviewers (PA and SR) identi-
fied studies from MEDLINE and Scopus databases since
conception to March 2014 using PubMed and Scopus
search engines. The following search terms were used:
(heart arrest or out of hospital cardiac arrest or ventricular
fibrillation or pulseless electrical activity or PEA or asys-
tole or cardiac arrest) and (epinephrine or adrenaline) and
(return of spontaneous circulation or ROSC or admission
or discharge or death or survival). Studies were firstly se-
lected based on title and abstracts, and full papers were
reviewed to make a final decision on selection.
Any type of study (that is, RCT, quasi-experimental
study, cohort, or cross sectional study) published in
English was selected if it met the following eligibility cri-
teria: studied in patients with out of hospital cardiac ar-
rest, compared clinical outcomes between prehospital
adrenaline and no administration, and had at least one
of these clinical outcomes of interest: ROSC, hospital
admission, survival to hospital discharge, or discharged
with CPC 1 or 2. Studies were excluded if there were in-
sufficient data for pooling and if authors did not provide
additional data after being contacted twice.
The short-term outcomes of interest included ROSC
and hospital admission and the long-term outcomes of
interest were survival to discharge and discharged with
CPC 1 or 2. The ROSC was defined according to indi-
vidual original studies as any sign of spontaneous circu-
lation including palpable pulse or measurable blood
pressure following CPR [13,16,26,27] occurring during
prehospital, at emergency department (ED) arrival, or
in-hospital. Survival to discharge referred to patients
who were still alive at discharge from hospital. Neuro-







Yanagawa, 2010 [15] 713 14 58
Hagihara, 2012 [12] 417,188 2,786 15,03
Hayashi, 2012 [13] 3,161 297 1,01
Nordseth, 2012 [14] 174 39 101
Goto, 2013 [36] 209,577 4,563 23,67
Neset, 2013 [35] 223 29 119
Pooled 421,459 3,165 16,32
aPrehospital ROSC. CI, confidence interval; n, number; ROSC, return of spontaneousGlasgow-Pittsburgh cerebral performance category scale,
which categorizes patients as CPC 1 to 5 as follows:
good performance, moderate, severe, coma/vegetative,
and death, respectively [14,18,26-28].
Data extraction
Data were extracted by two independent reviewers (PA
and SR). Study characteristics (that is, settings, study de-
signs, types of subjects, mean age and percentage of
males) were extracted. In addition, clinical data includ-
ing initial cardiac rhythms, dose and routes of adrenaline
administration, presumed cardiac etiologies, witnessed
cardiac arrest and bystander CPR status were also ex-
tracted. The numbers of subjects who did and did not
experience outcomes of interest among adrenaline ad-
ministration groups were also extracted. Any disagree-
ment was discussed with the senior author (AT).
Risk of bias assessment
The Newcastle-Ottawa Scale for assessing the quality of a
cohort study [29] was modified and used to assess risk of
bias for included cohort studies (see Additional file 1: Table
S2). This tool consists of five items, which are representa-
tive of out of hospital cardiac arrest cohorts, ascertainment
of exposure and outcomes, adjusting for confounders and
missing data. Each item was graded as low or high risk of
bias, and unclear if insufficient information.
Statistical analysis
The effect of adrenaline administration was estimated
for each study using risk ratio (RR) along with its 95%
confidence interval (CI). The RR was pooled across stud-
ies using the random-effect model if heterogeneity was
present [30], otherwise a fixed-effects model was applied.
The criteria for declaring heterogeneity was a P-value of
the Cochrane’s Q statistics <0.1 or I2 25% or higher [31].
Sources of heterogeneity were explored using Galbraith’s
plot and meta-regression analysis. Each potential vari-
able (that is, types of subjects, initial cardiac rhythms
and proportion of witnessed cardiac arrest) was fitted inital ROSC
Non-adrenaline group RR (95% CI)
ROSCa n
54 655 2.93 (1.74, 4.94)
0 23.042 402,158 3.24 (3.12, 3.35)
3 287 2,148 2.19 (1.9, 2.53)
14 73 2.01 (1.18, 3.43)
6 8,674 185,901 4.13 (4.0, 4.27)
12 104 2.11 (1.14, 3.92)
1 23,409 405,138 2.89 (2.36, 3.54)
circulation; RR, risk ratio.





Adrenaline group Non-adrenaline group RR (95% CI)
ROSCa n ROSCa n
Herlitz, 1995 [5] 910 164 390 117 520 1.87 (1.53, 2.28)
Guyette, 2004 [17] 298 74 268 18 30 0.46 (0.32, 0.65)
Ong, 2007 [16] 681 45 303 62 378 0.91 (0.64, 1.29)
Machida, 2012 [18] 492 21 49 204 443 0.93 (0.66, 1.31)
Pooled 2,381 304 1,010 401 1,371 0.93 (0.5, 1.75)
aOverall ROSC. CI, confidence interval; n, number; ROSC, return of spontaneous circulation; RR, risk ratio.
(A)
(B)
Figure 2 Forest (A) and funnel plot (B) of pooling of pre-hospital adrenaline effects on prehospital ROSC. AD, adrenaline; N, number of
subjects; Non-AD, non adrenaline; ROSC, return of spontaneous circulation; RR, risk ratio.
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plied by excluding candidate studies suspected to be a
source of heterogeneity.
Publication bias was assessed using a funnel plot and
Harbord’s test [32]. A contour-enhanced funnel plot was
applied to explore whether there was any cause of asym-
metry due to publication bias or heterogeneity [33]. All
analyses were performed using STATA version 12.0. A
P-value of less than 0.05 was considered as statistically
significant, except for the heterogeneity test in which
0.10 was used.(A)
(B)
Figure 3 Forest (A) and funnel plot (B) of pooling of prehospital adre
subjects; Non-AD, non adrenaline; ROSC, return of spontaneous circulation;Results
Eight-hundred and eighty-two studies and 804 studies
were identified, respectively, from PubMed and Scopus,
see Figure 1. Of these, 602 duplicated studies were ex-
cluded, leaving 1,084 studies for screening titles and ab-
stracts. Among them, 1,069 studies did not meet our
eligibility criteria and the reasons have been clearly de-
scribed in Figure 1, leaving 54 studies for review of full
papers. Of these, 39 studies were later excluded, which
finally resulted in 15 studies for inclusion in pooling data
[5,12-21,27,34-36].naline effects on overall ROSC. AD, adrenaline; N, number of
RR, risk ratio.
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scribed in Table 1. Of the 15 eligible studies, 14 were
observational studies and only 1 was a RCT [27]. All
studies were in adult patients except one which included
children [34]. Among 14 adult cohorts, 10 studies
[12-18,35-37] reported ROSC, 8 studies [5,13,14,16,18-21]
reported admission, 7 studies [5,14,16,18-20,35] reported
survival to discharge, and only 2 studies reported dis-
charged with CPC 1 or 2 [14,18]. All studies were EMS
based designs, except one study which was hospital-
based using a hospital cardiac arrest data registry [18].
Only five studies exclusively included patients with
non-trauma [13,14,16,17,35] whereas the others in-
cluded cohorts in which trauma patients were com-
bined with non-trauma cases [5,12,15,18-21,36]. Patients
with specific initial cardiac rhythms were isolated in
five studies, which included three pulseless electrical
activity (PEA) [14,19,21], one asystole [20] and one
ventricular fibrillation [5]. All studies compared admi-
nistration of a standard dose of adrenaline to no
administration. There were four studies [16,17,21,27]
which reported the amount of adrenaline administra-
tion which ranged from 1 to 5 mg. Since there was only
one RCT and one study in children, pooling of the
treatment effect versus no administration focused on
only thirteen adult cohorts.
Risk of bias assessment
Thirteen adult cohort studies were assessed for risk of
bias using the Newcastle-Ottawa scale (see Additional
file 1: Table S3). Eleven studies were low risk of bias for
representativeness of out of hospital cardiac arrest.
There were 11 studies which were graded as low risk of
bias for both ascertainment of adrenaline administration
and outcomes. Nine studies assessed treatment effects
by adjusting confounders, thus they were low risk of
confounding bias. Finally, 10 studies were graded as low







Herlitz, 1994 [20] 1,222 39 34
Herlitz, 1995 [5] 1,203 150 41
Herlitz, 1995 [19] 748 41 27
Ong, 2007 [16] 681 23 30
Vayrynen, 2008 [21] 789 198 70
Hayashi, 2012 [13] 3,161 432 1,01
Machida, 2012 [18] 492 18 49
Nordseth, 2012 [14] 174 49 10
Pooled 8,470 950 3,20Return of spontaneous circulation
Prehospital ROSC
Six adult cohorts [12-15,35,36] were included for pooling
adrenaline administration effects on prehospital ROSC
with sample sizes of 16,321 for adrenaline and 405,138
for non-adrenaline groups, see Table 2. The prehospital
adrenaline effect was highly heterogeneous across studies
(Q = 153.2, d.f. = 5, P <0.001 , I2 = 96.7%), see Figure 2A
and Table 2. A random-effects model was applied and
yielded a pooled RR of 2.89 (95% CI: 2.36, 3.54), indicating
that a patient receiving prehospital adrenaline was 2.89
times more likely to experience prehospital ROSC than
one not receiving prehospital adrenaline.
Galbraith plot and meta-regression suggested that type
of subjects (non-trauma or mixed non-trauma with
trauma) and arrest witnessed by bystander might be
sources of heterogeneity (data not shown). Thus, a sub-
group analysis was performed next by types of subjects
(that is, non-trauma only [13,14,35] and mixed trauma
and non-trauma cases [12,15,36]). Treatment effect was
homogeneous among non-trauma cases (Q = 0, d.f. = 2,
P <0.95, I2 = 0%), but it was still highly varied among
mixed cases (Q = 97, d.f. = 2, P <0.001, I2 = 97.9%). The
pooled RRs for these two subgroups were 2.18 (95% CI:
1.9, 2.49) and 3.55, 95% CI: 2.84, 4.44), respectively.
A funnel plot showed a departure from symmetry of the
funnel (see Figure 2B), but this was not detected by the
Harbord’s test (coefficient = −7.92, P = 0.134). However, a
contour-enhanced funnel plot was constructed to explore
any cause of asymmetry (see Additional file 1: Figure S1).
This suggested that all studies fell in the significant
area indicating that asymmetry of the funnel was more
likely due to missing studies (that is, publication bias)
than heterogeneity.
Overall return of spontaneous circulation
The effect of prehospital adrenaline on overall ROSC
was pooled based on four studies with a total sampleadmission
Non-adrenaline group RR (95% CI)
Admission n
4 51 878 1.95 (1.31, 2.91)
7 283 786 1.0 (0.85, 1.17)
6 55 472 1.28 (0.88, 1.86)
3 28 378 1.03 (0.6, 1.74)
3 54 86 0.45 (0.37, 0.55)
3 881 2,148 1.04 (0.95, 1.14)
155 443 1.05(0.71, 1.54)
1 25 73 1.42 (0.97, 2.06)
6 1,532 5,264 1.05 (0.8, 1.38)
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was highly heterogeneous (Q = 52.57, d.f. = 3, P <0.001,
I2 = 94.3%) with a pooled RR of 0.93 (95% CI: 0.5, 1.74),
see Table 3 and Figure 3A. This suggested no effect
of prehospital adrenaline on achieving overall ROSC.
No source of heterogeneity could be identified from
Galbraith’s plot or meta-regression analysis.
There was evidence of asymmetry from the funnel plot
and the Harbord’s test (coefficient = −9.27, P = 0.005),
see Figure 3B. The contour enhanced funnel plot
showed that 50% of the studies fell in both significant(A)
(B)
Figure 4 Forest (A) and funnel plot (B) of pooling of prehospital adre
number of subjects; Non-AD, non adrenaline; RR, risk ratio.and non-significant areas, indicating heterogeneity was
most likely the cause of asymmetry of the funnel (see
Additional file 1: Figure S2).
Hospital admission
Eight observational studies assessed the association of pre-
hospital adrenaline administration and hospital admission
[5,13,14,16,18-21]. The effect of adrenaline highly varied
across studies (Q = 77.08, d.f. = 7, P <0.001, I2 = 90.9%)
with a pooled RR of 1.05 (95% CI:0.80, 1.38), which was
not statistically significant, see Table 4 and Figure 4A.naline effects on overall hospital admission. AD, adrenaline; N,
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study [21] which included only non-trauma patients with
pulseless electrical activity. The degree of heterogeneity
decreased substantially (Q = 12.91, d.f. = 6, P = 0.045,
I2 = 53.5%) and with a pooled RR of 1.15 (95% CI: 1.00,
1.34). Excluding another study [20] which included only
patients with asystole did not improve the degree of he-
terogeneity (Q = 65.01, d.f. =6, P <0.001, I2 = 90.8%).
The funnel plot showed a little asymmetry of the
funnel, which corresponded with the Harbord’s test
(coefficient = 0.03, P = 0.988), see Figure 4B. A contour-
enhanced funnel plot showed that most studies fell in
the non-significant area, suggesting that asymmetry was
more likely due to heterogeneity (see Additional file 1:
Figure S3).
Survival to discharge
Data of seven cohorts [5,14,16,18-20,35] were used for
pooling effects of prehospital adrenaline administration
on survival to discharge, see Table 5. The pooled RR was
0.69 (95% CI: 0.48, 1.00) with a moderate degree of het-
erogeneity (Q = 9.1, d.f. = 6, P = 0.049, I2 = 34.1%), see
Table 5 and Figure 5A. This suggested that receiving
prehospital adrenaline yielded about a 31% lower chance
of discharge alive, but this was of borderline significance.
There was no evidence of asymmetry of the funnel
as suggested by the Harbord’s test (coefficient = −0.37,
P = 0.697) and the funnel plot, see Figure 5B.
Discussion
We performed a systematic review and meta-analysis to
assess the effects of prehospital administration of adren-
aline on short-term (that is, ROSC and hospital admis-
sion) and long term out of hospital cardiac arrest
outcomes (that is, survival to discharge and discharge with
CPC 1 or 2) relative to no administration. Pooled treat-
ment effects were performed based on four to eight adult
cohorts with total sample sizes of 2,381 to 421,459. Our







Herlitz, 1994 [20] 1,222 7 34
Herlitz, 1995 [5] 1,,203 50 41
Herlitz, 1995 [19] 748 4 27
Ong, 2007 [16] 681 1 30
Machida, 2012 [18] 492 8 49
Nordseth, 2012 [14] 174 1 10
Neset, 2013 [35] 223 14 11
Pooled 4,743 85 1,5significantly increased prehospital ROSC, but did not in-
crease the overall ROSC, hospital admission, or survival to
hospital discharge. However, the treatment effects on pre-
hospital ROSC may be prone to bias from missing studies.
Administration of adrenaline during CPR causes con-
striction of peripheral vessels, which subsequently in-
creases coronary and cerebral perfusion pressure [3].
Our findings support the effect of adrenaline in increa-
sing prehospital ROSC, which is similar to a previous
RCT [27] and systematic reviews by Lin et al. [24]. How-
ever, our effect size was more precise than the finding by
Lin et al. because the pooling was based on a larger
number of included studies than Lin et al., which was
based on only one study. In addition, our findings also
suggested the adrenaline effect on ROSC in both non-
trauma and the mix of trauma and non-trauma cases, al-
though the latter was highly heterogeneous. However,
there was no adrenaline effect on overall ROSC, which
might be due to variation in the definition and time of
ROSC assessment, that is, prehospital, ED, and admis-
sion [12,14,18,19,28,36]. Assessing ROSC at the ED or
on admission could be very different compared to pre-
hospital ROSC because of the quality of CPR, type of fa-
cility, and personnel and equipment used.
No other long term effects (that is, hospital admission
and survival to discharge) of prehospital adrenaline were
identified. This suggests that adrenaline itself may only
have efficacy for inducing prehospital ROSC. Ultimately,
survival to hospital discharge is determined more by the
underlying clinical condition of the patient; for example,
a patient with acute myocardial infarction may be more
likely to survive than a patient with end stage respiratory
disease, and yet most studies [5,14,18] did not report the
underlying diagnoses which leads to difficulties in inter-
preting the results. In addition, adrenaline is intrinsically
a short acting cardiovascular stimulant, which has a lim-
ited half-life, and it may be less likely to have a signifi-
cant effect on long term outcomes for this reason [3].
Assessing treatment effects without adjusting for thesee alive
Non-adrenaline group RR (95% CI)
Discharge n
4 13 878 1.37 (0.55, 3.42)
7 149 786 0.63 (0.47, 0.85)
6 12 472 0.57 (0.19, 1.75)
3 10 378 0.13 (0.02, 0.97)
64 443 1.13 (0.58, 2.22)
1 4 73 0.18 (0.02, 1.58)
9 21 104 0.58 (0.31, 1.09)
28 74 3,134 0.69 (0.48, 1.00)
(A)
(B)
Figure 5 Forest (A) and funnel plot (B) of pooling of prehospital adrenaline effects on survival to discharge. AD, adrenaline; D/C, survival
to discharge; N, number of subjects; Non-AD, non adrenaline; RR, risk ratio.
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bias the results.
Our study has a number of strengths. We pooled treat-
ment effects on most relevant clinical short- and long-
term outcomes. We attempted to identify the most rele-
vant studies by two independent reviewers using defined
search terms and strategies in order to reduce selection
bias. Exhaustive searching of the literature resulted in the
number of included studies from four to eight cohorts. Al-
though the number of included studies is still small, but, it
is larger than a previous systematic review [22], whichincluded five studies [5,16,27,38,39] with different study
designs. We explored possible sources of heterogeneity by
considering whether a bystander witnessed the arrest,
types of subjects and initial cardiac rhythms in a meta-
regression. In addition, an attempt was made to distin-
guish the cause of asymmetry of funnel plots to determine
if this was due to heterogeneity or missing studies.
However, our study has some weaknesses. Firstly, our
results might be subject to some bias because pooled
effects were based on only observational studies, which
could not adjust for several known and unknown
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with a proper sample size, say approximately 4,500 sub-
jects in total to detect a difference of prehospital ROSC
rate of 2.5. Secondly, a subgroup analysis could not be
flexibly done because of the small number of included
studies. Thirdly, insufficient information on study char-
acteristics resulted in limited exploration of sources of
heterogeneity. Finally, we did not pool more relevant
clinical outcomes (that is, sustained ROSC and discharge
with CPR 1 or 2) because data were not available.
Conclusions
In summary, prehospital adrenaline administration
might increase prehospital ROSC, but not for survival to
discharge in out of hospital cardiac arrest patients. How-
ever, our findings might be subject to bias from missing
studies.
Key messages
 Currently, there was only one RCT which compared
prehospital adrenaline administration versus placebo
among out of hospital cardiac arrest patients.
 Receiving prehospital adrenaline significantly
increased prehospital ROSC, but not for overall
ROSC, hospital admission, and survival to discharge.
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Additional file 1: This file contains Table S1. Search strategy,
Table S2. Modified Newcastle-Ottawa quality assessment scale for
cohort studies, Table S3. Risk of bias assessment for cohort study,
Figure S1. Contour-enhanced funnel plot of prehospital adrenaline
effect on prehospital ROSC, Figure S2. Contour-enhanced funnel plot
of prehospital adrenaline effect on overall ROSC, Figure S3. Contour-
enhanced funnel plot of prehospital adrenaline effect on hospital
admission, Figure S4. Contour-enhanced funnel plot of prehospital
adrenaline effect on survival to discharge.
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